Thymectomy for myasthenia gravis in children

Area of Science:

• Pediatric Neurology
• Autoimmune Disorders
• Surgical Management

Background:

• Myasthenia gravis (MG) is a rare autoimmune neuromuscular disease affecting children.
• Pediatric MG presents unique diagnostic and management challenges compared to adult-onset MG.
• Limited data exists on long-term outcomes of surgical interventions in childhood MG.

Purpose of the Study:

• To evaluate the efficacy and safety of thymectomy in pediatric patients diagnosed with myasthenia gravis.
• To assess the long-term outcomes and recovery rates following thymectomy in children with MG.
• To determine the optimal timing and surgical approach for thymectomy in childhood MG.

Main Methods:

• Retrospective analysis of eight pediatric patients (under 16) treated for myasthenia gravis over 12 years.
• Assessment of clinical presentation, disease progression, and response to medical management (cholinergic drugs, corticosteroids).
• Surgical intervention via median sternotomy thymectomy, followed by clinical assessment and long-term follow-up.

Main Results:

• Six girls and two boys presented with MG symptoms between ages 10-16; antibodies were negative in six patients.
• Medical management provided insufficient relief, necessitating thymectomy in all patients after an average of 12 months.
• Six patients achieved dramatic amelioration and complete recovery post-thymectomy (average follow-up 7.3 years); two are progressively improving.

Conclusions:

• Early thymectomy is a highly effective treatment for pediatric myasthenia gravis, leading to significant recovery.
• Thymectomy, performed via median sternotomy, demonstrated no postoperative morbidity or mortality in this cohort.
• The encouraging results support recommending early thymectomy for children diagnosed with myasthenia gravis.